NCT06661018View on ClinicalTrials.gov

Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 28, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

June 30, 2024

Conditions
ST Segment Elevation Myocardial Infarction (STEMI)Coenzyme Q10
Interventions
DRUG

Coenzyme Q 10

participant will receive STEMI standard treatment plus oral Coenzyme Q10 (chewable tablet) 100 mg / 12 hours for 8 weeks

DRUG

Placebo

participant will receive STEMI standard treatment plus placebo /12 hours for 8 weeks

Trial Locations (2)

50244

Dr. Kariadi Central General Hospital, Semarang

Unknown

Dr. Kariadi Central General Hospital, Semarang

All Listed Sponsors
lead

Universitas Diponegoro

OTHER

NCT06661018 - Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI | Biotech Hunter | Biotech Hunter